IPS Ventures
VC Fund
Seocho, South Korea
IPS Ventures is a VC fund in Seocho focused on Apps and Medical. IPS Ventures provides investment support to technology startups in South Korea.
- Total investments:
- 34
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries IPS Ventures invests in
Stages IPS Ventures invests in
Countries IPS Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $148k–$1.4M
- Series A
- $1.1M–$9M
Investment Focus
Industry
- Apps 2 (6%)
- Medical 2 (6%)
- Medical Device 2 (6%)
- Online Portals 2 (6%)
- Test and Measurement 2 (6%)
Stage
- Seed 5 (15%)
- Series A 4 (12%)
- Series B 1 (3%)
- Venture - Series Unknown 1 (3%)
Country
- South Korea 10 (29%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Park Jae-Pyeong
Senior Managing Director
|
Senior Managing Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications. | $22.6M / Venture - Series Unknown / Jun 10, 2026 | ||
| Ilias AI is a startup specializing in digital olfactory (scent) AI technology. It develops AI systems that can detect, analyze, and digitize smells for applications like security, safety, and medical diagnostics. The company aims to build a “scent data platform” that turns odors into measurable and usable AI dat | $177.8K / Seed / Jun 21, 2024 | ||
| Home Check provides interior inspection and home management services for private homes and apartment complexes. | $1.4M / Series A / Jan 26, 2024 | ||
| Huject is a Hanyang University laboratory startup company founded in 2020 with the goal of commercializing energy harvesting technology. The company develops and sells a wide range of products that use energy-harvesting source technology. Energy harvesting is an environmentally friendly energy technology that collects discarded energy and converts,stores, and uses it to generate electrical energy. | $1.4M / Seed / Nov 21, 2023 | ||
| WEMEET is a manufacturer and supplier of vegetable meat. | $147.9K / Seed / Oct 13, 2023 | ||
| Eleven Liter operates Lipet, an online health check solution for companion animals. | Convertible Note / Aug 22, 2023 | ||
| We are working to solve the issue of medical nonadherence, where patients don't follow their prescribed medical regimes. This is a common and costly problem, and can even result in serious consequences. Our proprietary smartwatch is able to tell what medicine users take, and when they take it. Our AI-based management platform then collects thedata and provides personalized healthcare services and insights. | $2.2M / Series A / Jul 10, 2023 | ||
| Medi Whale seeks to achieve sustainable healthcare where every eye can truly be the window to one’s health with our world's first-of-its-kind 1-stop AI screening platform solution for cardiovascular, renal, metabolic risk assessment, and eye disease diagnosis. Our AI Platform was developed through several clinical collaborations (Korea,Singapore, India, UK, and other European datasets) using structured longitudinal event-based datasets for the development of our retinal biomarker engines. RetiCVD® (cardiovascular disease risk assessment): Developed using coronary artery calcium (CAC) score, CAC is recognized as the gold standard for precise CVD risk calculation. Our CVD engine predicts the presence of CAC and provides a stratified probabilistic risk based on US ASCVD and EU SCORE guidelines.RetiCKD® (chronic kidney disease risk assessment): Developed using eGFR and full lab panel, our CKD engine has been demonstrated to achieve better predictive capability as compared to eGFR or full panel analysis.RetiEYE®: Referable Eye Disease engine detects and flags common aging-related eye modalities such as diabetic retinopathy, age-related macular degeneration, glaucoma, and cataract at its referable disease state.Medi Whale retinal-based systemic biomarkers have been clinically demonstrated to be non-inferior to current gold standards and are recognized by clinical and scientific communities with two Lancet Digital Health publications. | $9M / Series A / Apr 18, 2023 | ||
| Style Recipe is a fashion curation platform that offers customized fashion. | $243.4K / Seed / Jan 31, 2023 | ||
| PayWal is a payment platform that provides dedicated project teaming, task execution checks, and contract management services. Paywork platform offers features with the ability to provide various templates that are customizable and can be personalized by adding the company logo, name, and other information while also providing invoice draftingservices, enabling companies to generate invoices without any hassle. | $155.8K / Seed / Dec 20, 2022 | ||
| See all 34 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does IPS Ventures invest in?
IPS Ventures invests primarily in Apps, Medical and Medical Device startups, most often at Seed and Series A stage. Most of the 34 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is IPS Ventures's check size?
IPS Ventures typically joins rounds of $148k–$1.4M at Seed and $1.1M–$9M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds IPS Ventures participates in.
How do I contact IPS Ventures?
Public channels for IPS Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at IPS Ventures?
The team at IPS Ventures includes Park Jae-Pyeong (Senior Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
